Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Thomas E. Shelton"'
Autor:
Nikolaos Zacharakis, Lutfi M. Huq, Samantha J. Seitter, Sanghyun P. Kim, Jared J. Gartner, Sivasish Sindiri, Victoria K. Hill, Yong F. Li, Biman C. Paria, Satyajit Ray, Billel Gasmi, Chyi-chia Lee, Todd D. Prickett, Maria R. Parkhurst, Paul F. Robbins, Michelle M. Langhan, Thomas E. Shelton, Anup Y. Parikh, Shoshana T. Levi, Jonathan M. Hernandez, Chuong D. Hoang, Richard M. Sherry, James C. Yang, Steven A. Feldman, Stephanie L. Goff, Steven A. Rosenberg
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(16)
PURPOSE Metastatic breast cancer (mBrCa) is most often an incurable disease with only modest responses to available immunotherapies. This study investigates the immunogenicity of somatic mutations in breast cancer and explores the therapeutic efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508a2d3cb3dbe1c8ef86a22f14663f6c
https://pubmed.ncbi.nlm.nih.gov/35590150
https://pubmed.ncbi.nlm.nih.gov/35590150
Autor:
Steven A. Rosenberg, David S. Schrump, Isaac Kriley, Biman C. Paria, Scott Kivitz, Satyajit Ray, Todd Prickett, Thomas E. Shelton, Parisa Malekzadeh, Drew Deniger, Anna Pasetto, Jared J. Gartner, Li Jia, Yong-Chen Lu, Eric Tran, Paul F. Robbins, Maria Parkhurst, Winifred Lo
Supplementary Figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f59cb40fc83b120875be586c8356377
https://doi.org/10.1158/2326-6066.22542307.v1
https://doi.org/10.1158/2326-6066.22542307.v1
Autor:
Steven A. Rosenberg, David S. Schrump, Isaac Kriley, Biman C. Paria, Scott Kivitz, Satyajit Ray, Todd Prickett, Thomas E. Shelton, Parisa Malekzadeh, Drew Deniger, Anna Pasetto, Jared J. Gartner, Li Jia, Yong-Chen Lu, Eric Tran, Paul F. Robbins, Maria Parkhurst, Winifred Lo
Supplementary Tables 1 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5243610ee0a82f1512c4fa8320bda478
https://doi.org/10.1158/2326-6066.22542295
https://doi.org/10.1158/2326-6066.22542295
Autor:
Steven A. Rosenberg, David S. Schrump, Isaac Kriley, Biman C. Paria, Scott Kivitz, Satyajit Ray, Todd Prickett, Thomas E. Shelton, Parisa Malekzadeh, Drew Deniger, Anna Pasetto, Jared J. Gartner, Li Jia, Yong-Chen Lu, Eric Tran, Paul F. Robbins, Maria Parkhurst, Winifred Lo
Supplementary Table 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb0d974fa256b6955c32f62e5ff3aeb
https://doi.org/10.1158/2326-6066.22542301
https://doi.org/10.1158/2326-6066.22542301
Autor:
Steven A. Rosenberg, David S. Schrump, Isaac Kriley, Biman C. Paria, Scott Kivitz, Satyajit Ray, Todd Prickett, Thomas E. Shelton, Parisa Malekzadeh, Drew Deniger, Anna Pasetto, Jared J. Gartner, Li Jia, Yong-Chen Lu, Eric Tran, Paul F. Robbins, Maria Parkhurst, Winifred Lo
Adoptive cell therapy (ACT) with T cells targeting neoantigens can mediate durable responses in patients with metastatic cancer. Cell therapies targeting common shared antigens for epithelial cancers are not yet broadly available. Here, we report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822b2f7d9e39943192b97c1504a66ab5
https://doi.org/10.1158/2326-6066.c.6549862.v1
https://doi.org/10.1158/2326-6066.c.6549862.v1
Autor:
Steven A. Rosenberg, David S. Schrump, Isaac Kriley, Biman C. Paria, Scott Kivitz, Satyajit Ray, Todd Prickett, Thomas E. Shelton, Parisa Malekzadeh, Drew Deniger, Anna Pasetto, Jared J. Gartner, Li Jia, Yong-Chen Lu, Eric Tran, Paul F. Robbins, Maria Parkhurst, Winifred Lo
Supplementary Figures 1, 2, 3, 4, 6 and 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b41719cc05756eba4ba5d00b909bff
https://doi.org/10.1158/2326-6066.22542304
https://doi.org/10.1158/2326-6066.22542304
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
A CONSORT diagram of patients on trials not previously reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06da035f308bb598100adf8e71c56769
https://doi.org/10.1158/1078-0432.22481738.v1
https://doi.org/10.1158/1078-0432.22481738.v1
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
Purpose:Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TIL) can mediate durable responses in patients with metastatic melanoma. This retrospective analysis provides long-term follow-up and describes the effect of prior the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f65b05eb847244026d1327c65c3d70
https://doi.org/10.1158/1078-0432.c.6530759
https://doi.org/10.1158/1078-0432.c.6530759
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
Table S2 describes treatment characteristics by clinical response to treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6154f421dcba271477e13fdd4b2ee1
https://doi.org/10.1158/1078-0432.22481726
https://doi.org/10.1158/1078-0432.22481726
Autor:
Christine T. McGowan, Monica Epstein, Michelle M. Langhan, Paul F. Robbins, Stephanie L. Goff, Zulmarie Franco, Richard M. Sherry, Steven A. Rosenberg, David N. Danforth, James Chih-Hsin Yang, Samantha Seitter, Mackenzie L. Shindorf, Amy R. Copeland, Donald E. White, Thomas E. Shelton
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(19)
Purpose: Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TIL) can mediate durable responses in patients with metastatic melanoma. This retrospective analysis provides long-term follow-up and describes the effect of prior th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e48580b69f24b99440016de0251e861
https://pubmed.ncbi.nlm.nih.gov/34413160
https://pubmed.ncbi.nlm.nih.gov/34413160